Serum Institute of India 's Chief Executive Officer Adar Poonawalla has said their Covovax vaccine will get approval as a booster against COVID-19 in the next 10 to 15 days. The vaccine works very ...

Covovax vaccine has already been approved for restricted use in adults and children in the 12-17 age group. US FDA approves Moderna And Pfizer COVID-19 vaccines for children under 5, Bharat ...

In December, the country approved the Serum Institute of India's Covovax and Biological E's Corbevax for emergency use. It also approved ZyCoV-D vaccine - the world's first DNA vaccine against ...

Sanofi – which has taken a sub-5% equity stake in Novavax for $70 million – said the alliance will expand access to the biotech’s protein-based adjuvanted COVID vaccine Nuvaxovid/Covovax ...

COVID and flu season is coming sooner than you might think, and getting up to date with vaccines is the best way to protect yourself in the months ahead. This year’s COVID vaccine is a little ...

and Shah Capital says that is a consequence of “reactive leadership and outdated and old-fashioned marketing,” particularly with regard to its COVID-19 vaccine Nuvaxovid/Covovax. The hedge ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Nov 6 (Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organisations said ...

Some weeks Laja is doing outreach, spending her day educating a community about which vaccines she can provide and what diseases they prevent. “It’s my responsibility to tell the mothers to ...

There isn't any evidence 'that spacing out vaccines is better than giving them according to the schedule that has been studied and tested for many years by the CDC. In fact, by spacing out your ...

(File photo: IE) Serum Institute of India’s Chief Executive Officer Adar Poonawalla has said their Covovax vaccine will get approval as a booster against COVID-19 in the next 10 to 15 days.